实用药物与临床
實用藥物與臨床
실용약물여림상
Practical Pharmacy and Clinical Remedies
2015年
9期
1112-1115
,共4页
心脏介入术%对比剂肾病%抗炎
心髒介入術%對比劑腎病%抗炎
심장개입술%대비제신병%항염
Cardiac intervention%Contrast-induced nephropathy%Anti-oxidation
近年来,对比剂肾病( CIN)的发病率呈现逐渐上升的趋势. 丹红注射液是一种良好的循环改善制剂,在预防介入后CIN有确切的疗效. 本文就丹红注射液在抗氧化、调节NO 合成分泌、抑制炎症因子等途径预防CIN的机制进行综述.
近年來,對比劑腎病( CIN)的髮病率呈現逐漸上升的趨勢. 丹紅註射液是一種良好的循環改善製劑,在預防介入後CIN有確切的療效. 本文就丹紅註射液在抗氧化、調節NO 閤成分泌、抑製炎癥因子等途徑預防CIN的機製進行綜述.
근년래,대비제신병( CIN)적발병솔정현축점상승적추세. 단홍주사액시일충량호적순배개선제제,재예방개입후CIN유학절적료효. 본문취단홍주사액재항양화、조절NO 합성분비、억제염증인자등도경예방CIN적궤제진행종술.
In recent years,the incidence rate of contrast-induced nephropathy ( CIN) showed a gradual upward trend. Danhong injection is a good micro-circulation improving agent with an exact effect of preventive intervention af-ter CIN. This article reviewed the preventive mechanisms of danhong injection ( including anti-oxidation,regulating NO synthesis and secretion,inhibition of inflammatory cytokines and other means) in the treatment of CIN.